-
Markets
-
Aktien
Sustainable finance2025 Euronext ESG Trends ReportWeiterlesenA data-driven snapshot of how Euronext-listed companies are advancing their Environmental, Social and Governance (ESG) practices.
-
Indices
Access the white paperInvesting in the future of Europe with innovative indicesWeiterlesenThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
-
ETFs
The European market place for ETFsEuronext ETF EuropeWeiterlesenInvestors benefit from a centralised market place that will not only bring transparency but also better pricing due to the grouping of liquidity.
- Funds
-
Fixed Income
European Defence BondsGroupe BPCE lists the first bondWeiterlesenFirst financial institution in Europe to issue a bond dedicated to the defence sector
- Structured Products
-
Derivatives
Where European Government Bonds Meet the FutureFixed Income derivativesWeiterlesenTrade mini bond futures on main European government bonds
-
Rohstoffe
- Übersicht
- Kurse überblick
- Power Derivatives
- Milling Wheat derivatives
- Corn derivatives
- Spread contracts
- Rapeseed derivatives
- Durum Wheat derivatives
- Salmon derivatives
- Delivery & settlement
- Specifications & arrangements
- Commitments of Traders (CoT) report
- Commodity brokers
Building a sustainable and liquid power derivatives market.Euronext Nord Pool Power FuturesWeiterlesenEuronext and Nord Pool, the European power exchange, announced the launch of a dedicated Nordic and Baltic power futures market.
-
Resources
Designed to help students navigate the complexities of financial marketsEuronext Trading gameWeiterlesenJoin the Euronext Trading Game and step into capital markets. Learn from today’s leaders, explore sustainable opportunities, and trade with confidence.
Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 28 Nov 2025 07:50 CET |
ZELLUNA | Zelluna ASA Announces Appointment of Geir Christian Melen as New Chief Financial Officer | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 27 Nov 2025 08:35 CET |
ZELLUNA | Zelluna ASA: Disclosure of large shareholding | 20103010 Biotechnology | Major shareholding notifications |
| 25 Nov 2025 16:05 CET |
ZELLUNA | Zelluna ASA: Disclosure of large shareholding | 20103010 Biotechnology | Major shareholding notifications |
| 25 Nov 2025 12:09 CET |
ZELLUNA | ZELLUNA ASA: DISCLOSURE OF LARGE SHAREHOLDING | 20103010 Biotechnology | Major shareholding notifications |
| 25 Nov 2025 11:32 CET |
ZELLUNA | Zelluna ASA - Extraordinary General Meeting held on November 25, 2025 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 17 Nov 2025 10:33 CET |
ZELLUNA | Zelluna ASA: New share capital registered | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 04 Nov 2025 13:04 CET |
ZELLUNA | Zelluna ASA: Notice of extraordinary general meeting on 25 November 2025 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 04 Nov 2025 09:10 CET |
ZELLUNA | Zelluna ASA: Disclosure of large shareholding | 20103010 Biotechnology | Major shareholding notifications |
| 04 Nov 2025 08:28 CET |
ZELLUNA | Zelluna ASA: Disclosure of large shareholding | 20103010 Biotechnology | Major shareholding notifications |
| 04 Nov 2025 07:29 CET |
ZELLUNA | Zelluna ASA: Disclosure of large shareholding | 20103010 Biotechnology | Major shareholding notifications |
| 04 Nov 2025 07:00 CET |
ZELLUNA | Zelluna ASA - Ex. date | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 04 Nov 2025 00:58 CET |
ZELLUNA | Zelluna ASA - Key information relating to subsequent offering | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 04 Nov 2025 00:35 CET |
ZELLUNA | Zelluna ASA - Mandatory notification of trade | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 03 Nov 2025 23:52 CET |
ZELLUNA | Zelluna ASA - Successful private placement and retail offering | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 03 Nov 2025 16:47 CET |
ZELLUNA | Zelluna ASA - Contemplates private placement | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 03 Nov 2025 16:39 CET |
ZELLUNA | Zelluna ASA Reports Third Quarter 2025 Financial Results and Provides General Business Update | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 09 Oct 2025 07:58 CEST |
ZELLUNA | Zelluna Receives Positive MHRA Feedback and Strengthens UK Clinical Strategy for ZI-MA4-1 Paving the Way for First-in-Human Trials in the UK | 20103010 Biotechnology | Inside information |
| 10 Sep 2025 08:00 CEST |
ZELLUNA | Zelluna Announces Investor Forum on Science & Strategy to be held on Wednesday 17 September 2025 | 20103010 Biotechnology | Non-regulatory press releases |
| 20 Aug 2025 07:00 CEST |
ZELLUNA | Zelluna ASA Reports Second Quarter 2025 Financial Results and Provides General Business Update | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 14 Aug 2025 12:00 CEST |
ZELLUNA | Zelluna ASA: Invitation to Second Quarter 2025 results webcast presentation | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 03 Jul 2025 12:07 CEST |
ZELLUNA | Zelluna ASA - Grant of Share Options under Long-Term Incentive Program | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 25 Jun 2025 16:19 CEST |
ZELLUNA | Disclosure of share transfer from Inven2 AS | 20103010 Biotechnology | Non-regulatory press releases |
| 27 May 2025 13:51 CEST |
ZELLUNA | Disclosure of Shareholding - Gjelsten Holding AS | 20103010 Biotechnology | Major shareholding notifications |
| 27 May 2025 13:38 CEST |
ZELLUNA | ZLNA - New registered share capital | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 24 May 2025 08:37 CEST |
ZELLUNA | ZLNA - Issuance of shares through set-off of option exercise fee | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 08 May 2025 07:00 CEST |
ZELLUNA | Zelluna ASA Reports First Quarter 2025 Financial Results and Provides General Business Update | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 30 Apr 2025 08:00 CEST |
ZELLUNA | Zelluna ASA: Invitation to First Quarter 2025 results webcast presentation | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 29 Apr 2025 14:50 CEST |
ZELLUNA | Zelluna ASA - Annual General Meeting held on April 29, 2025 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 22 Apr 2025 07:47 CEST |
ZELLUNA | Zelluna Reaches Major Milestone with Manufacturing Process Established in Preparation for Clinical Entry of ZI-MA4-1, its Novel TCR-NK Therapy Targeting Solid Tumours | 20103010 Biotechnology | Inside information |
| 08 Apr 2025 08:43 CEST |
ZELLUNA | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 04 Apr 2025 15:21 CEST |
ZELLUNA | Zelluna ASA [ZLNA]: Notification of transaction by close associate of primary insider | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 04 Apr 2025 07:00 CEST |
ZELLUNA | Zelluna ASA [ZLNA]: Notice of Annual General Meeting on April 29, 2025 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 02 Apr 2025 07:00 CEST |
ZELLUNA | Zelluna ASA [ZLNA]: Annual Report 2024 | 20103010 Biotechnology | Annual financial and audit Reports |
| 01 Apr 2025 08:00 CEST |
ZELLUNA | Zelluna ASA [ZLNA]: Ex reverse share split today | 20103010 Biotechnology | Ex Date |
| 31 Mar 2025 17:16 CEST |
ZELLUNA | Zelluna ASA [ZLNA]: Registration of reverse share split | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 27 Mar 2025 15:27 CET |
ZELLUNA | Zelluna ASA [ZLNA]: Key information regarding reverse share split and change of ISIN | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 27 Mar 2025 10:21 CET |
ZELLUNA | Zelluna ASA [ZLNA]: Share capital increase registered | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 26 Mar 2025 13:55 CET |
ZELLUNA | Zelluna ASA [ZLNA]: Notification of transaction by close associate of primary insider | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 26 Mar 2025 13:22 CET |
ZELLUNA | Zelluna ASA [ZLNA]: Share capital increase resolution | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 03 Mar 2025 16:46 CET |
ULTIMOVACS | Zelluna ASA [ZLNA]: The first ever cell therapy company to list on the Oslo Stock Exchange following successful completion of the business combination and private placement | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 28 Feb 2025 14:45 CET |
ULTIMOVACS | Ultimovacs ASA: Approval and publication of prospectus | 20103010 Biotechnology | Prospectus / admission document |
| 13 Feb 2025 17:30 CET |
ULTIMOVACS | Ultimovacs ASA: Cancellation of subsequent repair offering | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 13 Feb 2025 09:09 CET |
ULTIMOVACS | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 31 Jan 2025 07:00 CET |
ULTIMOVACS | Ultimovacs ASA Reports Fourth Quarter 2024 Financial Results and Provides General Business Update | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 27 Jan 2025 08:47 CET |
ULTIMOVACS | Ultimovacs ASA: Invitation to fourth quarter 2024 results webcast presentation | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 27 Jan 2025 08:41 CET |
ULTIMOVACS | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 16 Jan 2025 14:01 CET |
ULTIMOVACS | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 09 Jan 2025 12:00 CET |
ULTIMOVACS | Ultimovacs ASA: Notification of major holdings | 20103010 Biotechnology | Major shareholding notifications |
| 09 Jan 2025 10:00 CET |
ULTIMOVACS | Ultimovacs ASA - Extraordinary General Meeting held on January 9, 2025 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 08 Jan 2025 12:00 CET |
ULTIMOVACS | Ultimovacs ASA - Disclosure of voting rights of Extraordinary General Meeting | 20103010 Biotechnology | Total number of voting rights and capital |